At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 20 target
Drug / intervention
ARC-IM Investigational System implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury
In Brief
A clinical study evaluating ARC-IM Investigational System implantation for Spinal Cord Injuries. Currently recruiting, targeting 20 participants across 1 site.
Detailed Summary
The HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to improve hemodynamic management and trunk control in people with sub-acute or chronic spinal cord injury (\>= 1 month post injury) between C3 and T6 inclusive, who suffer from orthostatic hypotension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injuries
CountriesSwitzerland
Collaborators--
Timeline
N/ARecruiting
2022202320242025202620272028202920302031
First PostedNov 2021
Enrollment StartNov 2021
TodayJul 2026
Primary CompletionDec 2030
First PostedNov 8, 2021
Enrollment StartNov 29, 2021
Primary CompletionDec 31, 2030
TodayJul 1, 2026
Enrollment to primary: 9.1 yearsPosted 4.6 years agoPrimary completion in 4.5 years
Interventions
ARC-IM Investigational System implantationdevice
Implantation of a stimulation lead on the low thoracic level of the spinal cord and implantation of a neurostimulator in the abdominal region.